Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil in Rapid Sequence Induction
NCT01259648Phase 4Completed
- Sponsor
- CHU Nîmes
- Start
- Mar 2011
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of remifentanil in tachycardia, sponsored by CHU Nîmes. Started Mar 2011; status: completed.
02
Drugs
remifentanil
03
Conditions
tachycardia
Beyond the preview
Go deeper on NCT01259648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01259648.